Art

J-GLOBAL ID：201702234638875269   Reference number：17A1697466

Unmet needs in the first-line treatment of follicular lymphoma

濾胞性リンパ腫の第一選択治療における満たされていない要求

Author (5)： CASULO C. (Univ. Rochester Medical Center, New York) ,  NASTOUPIL L. (MD Anderson Cancer Center, Houston) ,  FOWLER N. H. (MD Anderson Cancer Center, Houston) ,  FRIEDBERG J. W. (Univ. Rochester Medical Center, New York) ,  FLOWERS C. R. (Emory Univ., Atlanta, USA)
Material： Annals of Oncology  (Ann Oncol)
Volume： 28  Issue： 9  Page： 2094-2106  Publication year： Sep. 2017 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Lymphoma, Follicular ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1697466&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (3)： Tumors(=neoplasms)of digestive system  (GH04000D) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (4)： Doxorubicin ,  Cyclophosphamid ,  Vincristine ,  Prednisone

Reference (104)：

• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
• Johnson PW, Rohatiner AZ, Whelan JS et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995; 13: 140-147.
• Swenson WT, Wooldridge JE, Lynch CF et al. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 2005; 23: 5019-5026.
• Tan D, Horning SJ, Hoppe RT et al. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 2013; 122: 981-987.
• Salles G, Seymour JF, Offner F et al. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 2011; 377: 42-51.

Terms in the title (2)： 濾胞性リンパ腫 ,  治療